More evidence to support Thromboelastometry-based restrictive transfusion management to help avoid unnecessary plasma and platelet transfusion. . It is still common practice to correct abnormal standard laboratory test results, such as increased INR or low platelet count, prior to invasive interventions, such as tracheostomy, central venous catheter insertion or liver biopsy, in critically ill patients. Data suggest that 30–90 % of plasma transfused for these indications is unnecessary and puts the patient at risk.
Prophylactic plasma and platelet transfusion in the critically Ill patient: just useless and expensive or even harmful?
Violeta is based in the Hunter Valley NSW